A carregar...
Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone
PURPOSE: The aim of this study was to examine whether decitabine priming prior to low-dose chemotherapeutic regimens could improve outcomes in patients with myelodysplastic syndromes—refractory anemia with excess of blasts (MDS-RAEB). METHODS: The current retrospective analysis included all MDS-RAEB...
Na minha lista:
Publicado no: | J Cancer Res Clin Oncol |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Springer Berlin Heidelberg
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5384967/ https://ncbi.nlm.nih.gov/pubmed/28108816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-016-2331-0 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|